Skip to Content

Join the 'Solid Tumors' group to help and get support from people like you.

Solid Tumors News

New Trial Cancer Drug, Ulixertinib, Shows Promise Against Wide Range of Tumors

Posted 15 Dec 2017 by Drugs.com

FRIDAY, Dec. 15, 2017 – A new drug that targets a genetic flaw common to most cancer cells is showing potency against many tumor types. The preliminary trial of a drug called ulixertinib was conducted with 135 patients who had already failed treatments for one of a variety of advanced, solid tumors. Researchers led by Dr. Ryan Sullivan, of Massachusetts General Hospital, said ulixertinib did ...

Many Cancer Patients Skimp on Treatment Due to Cost

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals. Commissioned by the American Society of Clinical Oncology (ASCO), the report found that 27 percent of cancer survivors or close relatives of a cancer patient said they'd skipped doctor visits or taken other steps ...

Fewer Uninsured Cancer Patients After Medicaid Expansion

Posted 27 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 27, 2017 – States that expanded Medicaid under the Affordable Care Act halved the number of uninsured cancer patients, a new U.S. study finds. This matters because "uninsured cancer patients are more likely to go without needed care and treatment, such as radiation therapy or surgery to remove tumors," said study lead author Dr. Fumiko Chino. She is a radiation oncology resident ...

New Guideline Aims to Help Doctors Diagnose Head, Neck Masses

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – Neck masses are common in adults, but the cause is often hard to pinpoint. Now, doctors have a new guideline to help them make that call. The guideline from the American Academy of Otolaryngology – Head and Neck Surgery dovetails with a rise in head and neck cancers related to the sexually transmitted human papilloma virus (HPV). "A neck mass may indicate a serious ...

Many May Get Hospice Care Too Late

Posted 12 Sep 2017 by Drugs.com

TUESDAY, Sept. 12, 2017 – Despite a growing list of debilitating symptoms during the final months of life, most seniors never receive end-of-life hospice care – or they delay doing so until their last few weeks of life, new research finds. "The main message is that the duration of hospice is very short," explained lead study author Dr. Thomas Gill. This, despite the fact that his team ...

FDA Clears Expanded Use of Cooling Cap to Reduce Hair Loss During Chemotherapy

Posted 6 Jul 2017 by Drugs.com

July 3, 2017 – Today, the U.S. Food and Drug Administration cleared the expanded use of a cooling cap, DigniCap Cooling System, to reduce hair loss (alopecia) during chemotherapy. This is the first cooling cap cleared by the agency for use in cancer patients with solid tumors. “We are pleased to expand the use of this product for cancer patients with solid tumors to potentially minimize c ...

'Couch Potatoes' May Face Higher Risk of Kidney, Bladder Cancers

Posted 15 Jun 2017 by Drugs.com

THURSDAY, June 15, 2017 – Add greater risk of kidney and bladder cancer to the long list of why a lifetime of sitting on the sofa isn't good for your health, a new study suggests. Specifically, lifetime recreational inactivity was associated with a 73 percent increased risk of bladder cancer and a 77 percent increased risk of kidney cancer. The findings add to growing evidence that inactivity ...

FDA Approves Keytruda (pembrolizumab) as First Cancer Treatment for any Solid Tumor with a Specific Genetic Feature

Posted 25 May 2017 by Drugs.com

May 23, 2017 – The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time the agency has approved a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated. Keytruda (pembrolizumab) is indicated for the treatment of adult ...

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and ...

Zejula Approved for Certain Female Cancers

Posted 28 Mar 2017 by Drugs.com

TUESDAY, March 28, 2017 – Zejula (niraparib) has been approved by the U.S. Food and Drug Administration to treat adult women with recurring cancers of the ovaries, fallopian tubes or abdominal wall (peritoneum) whose tumors have shrunk in response to platinum-based chemotherapy. Citing the National Cancer Institute, the FDA said in a news release that more than 22,000 women are expected to be ...

Another Study Ties Obesity to Certain Cancers

Posted 1 Mar 2017 by Drugs.com

WEDNESDAY, March 1, 2017 – Carrying extra weight increases the risk of a number of cancers, a new review reports. Additional pounds appear to particularly influence the risk of cancers related to the digestive organs or those driven by hormonal abnormalities, according to the review's European authors. The evidence is so strong at this point that important organizations such as the International ...

Cancer Survivors Gain From Web-Based Health Care

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch ...

Benign 'Toothlet' Tumor Found in 255 Million-Year-Old Fossil

Posted 8 Dec 2016 by Drugs.com

THURSDAY, Dec. 8, 2016 – A fossil of a distant ancestor of today's mammals – which include humans – shows evidence of a benign tumor of the jaw, scientists report. The finding pushes back by hundreds of millions of years the advent of these "toothlet" tumors, called odontomas, says a team from the University of Washington in Seattle. The researchers discovered the compound odontoma tumor in ...

Worldwide Cancer Rates Up More Than One-Third in Past Decade: Report

Posted 4 Dec 2016 by Drugs.com

SATURDAY, Dec. 3, 2016 – Cancer cases rose 33 percent worldwide in the past 10 years, a new study shows. In 2015, there were 17.5 million diagnoses and 8.7 million deaths in the world from the disease, the researchers found. The rise in cancer cases was mainly due to population aging and growth, along with changes in age-specific cancer rates, according to the Global Burden of Disease Cancer ...

Archeological Finds Push First Known Cancer Back 2 Million Years

Posted 29 Jul 2016 by Drugs.com

FRIDAY, July 29, 2016 – Researchers report that they have unearthed the earliest evidence of bone tumors and cancers, dating back almost 2 million years. The discoveries challenge the belief that cancer is a disease of modern life, the study authors said. "Modern medicine tends to assume that cancers and tumors in humans are diseases caused by modern lifestyles and environments. Our studies show ...

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, hydroxyurea, Keytruda, Hydrea, Taxotere, pembrolizumab, bevacizumab, docetaxel, Droxia, view more... Methotrexate LPF Sodium, idarubicin, Idamycin PFS, Trexall, Folex PFS, Mylocel, Idamycin